Featured Image

Why is it important?

Current drug options including antispasmodic, antidiarrheals, rifaximin, antidepressants, Laxatives and motility accelerants are limited by barely ideal efficacy or side-effect. CD4+ T-cells from IBS-D patients exhibit immune activation, but this did not appear to correlate with psychological stress measurements or changing symptoms over time. It can be said that CD4+ T-cell cytokines and gut homing reveals immune activation in IBS and is largely confined to IBS-D patients but requires further investigation. Probiotics is a safety choice to improve the overall symptoms for IBS patient. The human gut microbiome is genetically diverse, expressing approximately 150-times more genes than the human host. Since it is agreed that the majority of the bacteria commonly identified in the microbiome cannot be routinely cultured using traditional laboratory techniques (80% or greater) [159]. Probiotic supplements are thought to improve IBS symptoms through manipulation of the gut microbiota, but the exact mechanisms of probiotics in the human body are not fully understood.

Read the Original

This page is a summary of: Conventional and Alternative Measures for IBS Management, Acta Scientific Gastrointestinal Disorders, October 2019, Acta Scientifica Publications Pvt. Ltd.,
DOI: 10.31080/asgis.2019.02.0088.
You can read the full text:

Read

Contributors

The following have contributed to this page